PT Siloam International Hospitals Tbk

Symbol: SILO.JK

JKT

2610

IDR

Market price today

  • 34.7401

    P/E Ratio

  • -6.0528

    PEG Ratio

  • 33.88T

    MRK Cap

  • 0.01%

    DIV Yield

PT Siloam International Hospitals Tbk (SILO-JK) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.36%

Operating Profit Margin

0.16%

Net Profit Margin

0.08%

Return on Assets

0.09%

Return on Equity

0.13%

Return on Capital Employed

0.21%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Care Facilities
CEO:Paulus Sujono
Full-time employees:14142
City:Tangerang
Address:Gedung Fakultas Kedokteran
IPO:2013-09-12
CIK:

PT Siloam International Hospitals Tbk, together with its subsidiaries, provides healthcare services in Indonesia. It also engages in setting up and managing hospitals. The company offers specialist and general medical services, including complex surgical procedures, laboratory services, radiology and imaging services, diagnostic, and emergency services. Its hospitals provide services in the areas of pediatrics, neurology, ENT, general surgery, emergency, nephrology, cardiology, oncology, obstetrics and gynecology, gastroenterology, ophthalmology, pulmonology, internal medicines, orthopedics, urology, anesthesiology, dentistry, dermatology, geriatric and nuclear medicines, pathology, plastic surgery, and psychiatry. The company operates 40 hospitals with 8,450 beds in Sumatra, Java, Bali, Kalimantan, Sulawesi, Nusa Tenggara Timur, Nusa Tenggara Barat, and Bangka. In addition, it engages in trading, development, mining, agriculture, service, land transportation, industry, workshop printing, plantation, forestry, electrical, mechanical, engineering, construction, agribusiness, and real estate businesses; computer programming activities; provision of management consulting, trust, financing, financial entities, retail, professional, and scientific and technical activities; and web portal and/or digital platform business. The company was formerly known as PT Sentralindo Wirasta. PT Siloam International Hospitals Tbk was founded in 1996 and is headquartered in Tangerang, Indonesia.

General Outlook

When we look at how much money they make before expenses, they keep 0.362% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.156%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.084%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.085% return, is a testament to PT Siloam International Hospitals Tbk's adeptness in optimizing resource deployment. PT Siloam International Hospitals Tbk's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.127%. Furthermore, the proficiency of PT Siloam International Hospitals Tbk in capital utilization is underscored by a remarkable 0.214% return on capital employed.

Stock Prices

PT Siloam International Hospitals Tbk's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2480, while its low point bottomed out at $2360. This variance in figures offers investors a lucid insight into the roller-coaster ride that is PT Siloam International Hospitals Tbk's stock market.

Liquidity Ratios

Analyzing SILO.JK liquidity ratios reveals its financial health of the firm. The current ratio of 105.07% gauges short-term asset coverage for liabilities. The quick ratio (92.23%) assesses immediate liquidity, while the cash ratio (33.19%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio105.07%
Quick Ratio92.23%
Cash Ratio33.19%

Profitability Ratios

SILO.JK profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 12.51% underscores its earnings before tax deductions. The effective tax rate stands at 29.84%, revealing its tax efficiency. The net income per EBT, 67.43%, and the EBT per EBIT, 80.34%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 15.57%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin12.51%
Effective Tax Rate29.84%
Net Income per EBT67.43%
EBT per EBIT80.34%
EBIT per Revenue15.57%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.05, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding92
Days of Inventory Outstanding10
Operating Cycle65.64
Days of Payables Outstanding31
Cash Conversion Cycle35
Receivables Turnover6.52
Payables Turnover11.83
Inventory Turnover37.78
Fixed Asset Turnover1.49
Asset Turnover1.01

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 163.30, and free cash flow per share, 26.08, depict cash generation on a per-share basis. The cash per share value, 76.80, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.18, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share163.30
Free Cash Flow per Share26.08
Cash per Share76.80
Operating Cash Flow Sales Ratio0.18
Free Cash Flow to Operating Cash Flow Ratio0.16
Cash Flow Coverage Ratio2.05
Short Term Coverage Ratio2.35
Capital Expenditure Coverage Ratio1.19
Dividend Paid and Capex Coverage Ratio1.19
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 9.07%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.13, we discern the balance between debt and equity financing. The long-term debt to capitalization, 1.67%, and total debt to capitalization, 11.58%, ratios shed light on its capital structure. An interest coverage of 33.28 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio9.07%
Debt Equity Ratio0.13
Long Term Debt to Capitalization1.67%
Total Debt to Capitalization11.58%
Interest Coverage33.28
Cash Flow to Debt Ratio2.05
Company Equity Multiplier1.44

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 861.68, provides a glimpse into top-line earnings distributed across each share. Net income per share, 93.27, reflects the portion of profit attributed to each share. The book value per share, 609.51, represents the net asset value distributed per share, while the tangible book value per share, 582.22, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share861.68
Net Income Per Share93.27
Book Value Per Share609.51
Tangible Book Value Per Share582.22
Shareholders Equity Per Share609.51
Interest Debt Per Share53.82
Capex Per Share-109.95

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 17.57%, indicates top-line expansion, while the gross profit growth, 3.16%, reveals profitability trends. EBIT growth, 70.69%, and operating income growth, 70.69%, offer insights into operational profitability progression. The net income growth, 73.91%, showcases bottom-line expansion, and the EPS growth, 31.85%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth17.57%
Gross Profit Growth3.16%
EBIT Growth70.69%
Operating Income Growth70.69%
Net Income Growth73.91%
EPS Growth31.85%
EPS Diluted Growth31.63%
Weighted Average Shares Growth31.90%
Weighted Average Shares Diluted Growth32.11%
Dividends per Share Growth-22.56%
Operating Cash Flow Growth40.37%
Free Cash Flow Growth115.10%
10-Year Revenue Growth per Share188.30%
5-Year Revenue Growth per Share87.89%
3-Year Revenue Growth per Share57.47%
10-Year Operating CF Growth per Share614.43%
5-Year Operating CF Growth per Share932.01%
3-Year Operating CF Growth per Share57.08%
10-Year Net Income Growth per Share1466.59%
5-Year Net Income Growth per Share7396.51%
3-Year Net Income Growth per Share943.28%
10-Year Shareholders Equity Growth per Share216.84%
5-Year Shareholders Equity Growth per Share26.10%
3-Year Shareholders Equity Growth per Share32.82%
Receivables Growth24.89%
Inventory Growth0.84%
Asset Growth13.62%
Book Value per Share Growth-13.72%
Debt Growth26.27%
SGA Expenses Growth157.74%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 27,499,190,536,000, captures the company's total value, considering both debt and equity. Income quality, 1.73, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 4.43%, indicates the value of non-physical assets, and capex to operating cash flow, -68.04%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value27,499,190,536,000
Income Quality1.73
Sales General and Administrative to Revenue0.06
Intangibles to Total Assets4.43%
Capex to Operating Cash Flow-68.04%
Capex to Revenue-12.76%
Capex to Depreciation-151.53%
Stock-Based Compensation to Revenue0.11%
Graham Number1130.98
Return on Tangible Assets11.54%
Graham Net Net-27.69
Working Capital583,575,000,000
Tangible Asset Value7,561,152,000,000
Net Current Asset Value202,262,000,000
Average Receivables1,393,999,500,000
Average Payables482,742,500,000
Average Inventory202,728,500,000
Days Sales Outstanding51
Days Payables Outstanding25
Days of Inventory On Hand10
ROIC15.25%
ROE0.15%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.28, and the price to book ratio, 4.28, reflect the market's valuation relative to the company's book value. The price to sales ratio, 2.93, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 100.09, and price to operating cash flows, 15.98, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio4.28
Price to Book Ratio4.28
Price to Sales Ratio2.93
Price Cash Flow Ratio15.98
Price Earnings to Growth Ratio-6.05
Enterprise Value Multiple12.60
Price Fair Value4.28
Price to Operating Cash Flow Ratio15.98
Price to Free Cash Flows Ratio100.09
Price to Tangible Book Ratio3.54
Enterprise Value to Sales2.46
Enterprise Value Over EBITDA10.23
EV to Operating Cash Flow13.10
Earnings Yield4.32%
Free Cash Flow Yield2.39%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of PT Siloam International Hospitals Tbk (SILO.JK) on the JKT in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 34.740 in 2024.

What is the ticker symbol of PT Siloam International Hospitals Tbk stock?

The ticker symbol of PT Siloam International Hospitals Tbk stock is SILO.JK.

What is company IPO date?

IPO date of PT Siloam International Hospitals Tbk is 2013-09-12.

What is company current share price?

Current share price is 2610.000 IDR.

What is stock market cap today?

The market cap of stock today is 33883593678000.000.

What is PEG ratio in 2024?

The current -6.053 is -6.053 in 2024.

What is the number of employees in 2024?

In 2024 the company has 14142.